
Neuland Laboratories Limited
NSE:NEULANDLAB.NS
Overview | Financials
Company Name | Neuland Laboratories Limited |
Symbol | NEULANDLAB.NS |
Currency | INR |
Price | 11,501.8 |
Market Cap | 147,566,302,325 |
Dividend Yield | 0.16% |
52-week-range | 5,540.1 - 18,100 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Davuluri Sucheth Rao |
Website | https://www.neulandlabs.com |
An error occurred while fetching data.
About Neuland Laboratories Limited
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson. It also provides custom manufacturing solutions, as well as peptide
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD